Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1566942

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1566942

Bionic Smart Knee Market By Material (Titanium, Graphite) , By End User (Hospitals, Orthopedic Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Business License)
USD 4425
PDF (Enterprise User License) & Excel (Data Pack) & Free Update
USD 7412

Add to Cart

Bionic Smart Knee Market

The bionic smart knee market was valued at $1.3 billion in 2023 and is projected to reach $2.8 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

A bionic smart knee is a unique prosthetic device utilized for knee replacement. The device is equipped with sensors, microprocessors, and Bluetooth technology, which facilitate the replacement procedure. This smart knee imitates the natural functions of a human knee, along with enhancing comfort and mobility. The primary features of bionic smart knee include its dynamic adjustment capabilities and remarkable gait analysis. Moreover, the device's connectivity features enable its integration with external devices or mobile apps, allowing users to monitor their performance and customize the settings or performance.

Advancements in technology and material sciences are driving the growth of the bionic smart knee market as these upgraded devices offer refined functionality and experience to the users. In addition, rise in the prevalence of mobility issues and knee injuries, along with surge in awareness regarding the availability of advanced therapeutics is boosting the adoption of bionic smart knee. An emerging trend in the bionic smart knee market is the neuroprosthetic regulation of the device. Control of the smart knee through neural abilities is anticipated to amplify the imitation of natural human gait by the device. To facilitate neural control, the agonist and antagonist muscle pairs critical for knee movement need to be surgically connected to mimic the natural dynamics.

However, the availability of prosthetic devices and the facility to undergo a successful replacement are majorly restricted to developed regions, which hampers the market growth. In addition, the high cost of smart knee administration, maintenance, and insurance coverage prevents budget-sensitive patients from undergoing replacement, which limits the widespread expansion of the market. According to an article by the U.S. News & World Report-an American news magazine-on an average, robotic smart knee replacements cost around $2,400 higher than the conventional replacement surgeries. On the contrary, the market is poised for lucrative opportunities due to the advent of remote health. Bionic smart knee enables remote checkups and post-operative monitoring, eliminating the hassle of multiple hospital visits after surgery.

Segment Review

The bionic smart knee market is segmented into material, end user, and region. On the basis of material, the market is bifurcated into titanium and graphite. As per end user, it is divided into hospitals, orthopedic clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of material, the titanium segment dominates the bionic smart knee market.

As per end user, hospitals are the leading segment in the market.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global bionic smart knee market include Stryker Corporation., Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Johnson & Johnson, B. Braun Melsungen AG, Medtronic, Ossur, Wright Medical Group N.V., Exactech, Inc., and ConforMIS, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles

Key Market Segments

By Material

  • Titanium
  • Graphite

By End User

  • Hospitals
  • Orthopedic Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Stryker Corporation.
    • Zimmer Biomet Holdings, Inc.
    • Smith & Nephew plc
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Medtronic
    • Ossur
    • Wright Medical Group N.V.
    • Exactech, Inc.
    • ConforMIS, Inc.
Product Code: A323975

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIONIC SMART KNEE MARKET, BY MATERIAL

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Material
  • 4.2. Titanium
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Graphite
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BIONIC SMART KNEE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Orthopedic Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: BIONIC SMART KNEE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Material
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Bionic Smart Knee Market
      • 6.2.5.1. Market Size and Forecast, By Material
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Bionic Smart Knee Market
      • 6.2.6.1. Market Size and Forecast, By Material
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Bionic Smart Knee Market
      • 6.2.7.1. Market Size and Forecast, By Material
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Material
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Bionic Smart Knee Market
      • 6.3.5.1. Market Size and Forecast, By Material
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Bionic Smart Knee Market
      • 6.3.6.1. Market Size and Forecast, By Material
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Bionic Smart Knee Market
      • 6.3.7.1. Market Size and Forecast, By Material
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Bionic Smart Knee Market
      • 6.3.8.1. Market Size and Forecast, By Material
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Bionic Smart Knee Market
      • 6.3.9.1. Market Size and Forecast, By Material
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Bionic Smart Knee Market
      • 6.3.10.1. Market Size and Forecast, By Material
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Material
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Bionic Smart Knee Market
      • 6.4.5.1. Market Size and Forecast, By Material
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Bionic Smart Knee Market
      • 6.4.6.1. Market Size and Forecast, By Material
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Bionic Smart Knee Market
      • 6.4.7.1. Market Size and Forecast, By Material
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Bionic Smart Knee Market
      • 6.4.8.1. Market Size and Forecast, By Material
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Bionic Smart Knee Market
      • 6.4.9.1. Market Size and Forecast, By Material
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Bionic Smart Knee Market
      • 6.4.10.1. Market Size and Forecast, By Material
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Material
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Bionic Smart Knee Market
      • 6.5.5.1. Market Size and Forecast, By Material
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Bionic Smart Knee Market
      • 6.5.6.1. Market Size and Forecast, By Material
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Bionic Smart Knee Market
      • 6.5.7.1. Market Size and Forecast, By Material
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Bionic Smart Knee Market
      • 6.5.8.1. Market Size and Forecast, By Material
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Stryker Corporation.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Zimmer Biomet Holdings, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Smith And Nephew Plc
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Johnson And Johnson
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. B. Braun Melsungen AG
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Ossur
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Wright Medical Group N.V.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Exactech, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. ConforMIS, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!